Zopapogene imadenovec
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Non-replicating adenoviral vectors for cancer gene therapy.
Journal: Advances in cancer research
Published: June 05, 2026
Therapeutic vaccination for active induction of T cell immunity against cancer, ready for a rich harvest after 40 years.
Journal: Journal for immunotherapy of cancer
Published: February 10, 2026
The Efficacy and Safety of Systemic Treatment for Managing Recurrent Respiratory Papillomatosis: A Systematic Review and Meta-analysis.
Journal: Journal of voice : official journal of the Voice Foundation
Published: December 05, 2025
Zopapogene Imadenovec: First Approval.
Journal: Molecular diagnosis & therapy
Published: September 21, 2025
From surgery to immunotherapy: Papzimeos as the first FDA-approved therapy for recurrent respiratory papillomatosis (RRP).
Journal: Annals of medicine and surgery (2012)
Published: September 15, 2025
In Reference to A Clinical Consensus Statement on Pulmonary Recurrent Respiratory Papillomatosis.
Journal: The Laryngoscope
Published: September 06, 2025
Showing 1-6 of 6
Last Updated: 06/30/2026